• Regenerative Medical Technology Group launched an ISSCA Longevity and Adjunctive Therapies Certification targeting physicians in longevity-focused practices.
• Program covers multi-modality training, including plasma exchange, peptide medicine, IV therapy, AI tools, and device-based therapies such as PEMF.
• Certification is positioned as an education product, not confirmation that all covered therapies are offered at its Cellular Hope Institute clinic.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202610050701ACCESSWRNAPR_____1232627) on October 05, 2026, and is solely responsible for the information contained therein.